Authors' Response to Letter "Reliability Assurance of EML4-ALK Rearrangement Detection in Non-Small Cell Lung Cancer: A Methodological and Statistical Issue"

被引：0
|
作者：
Li, Yulong [1 ,2 ,3 ]
Li, Jinming [1 ,2 ,3 ]
Zhang, Rui [1 ,3 ]
机构：
[1] Beijing Hosp, Natl Ctr Clin Labs, 1 Dahua Rd, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[3] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 07期
关键词：
D O I：
10.1016/j.jtho.2016.04.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E93 / E94
页数：3
相关论文
共 50 条
  • [31] Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
    Lo Russo, Giuseppe
    Imbimbo, Martina
    Corrao, Giulia
    Proto, Claudia
    Signorelli, Diego
    Vitali, Milena
    Ganzinelli, Monica
    Botta, Laura
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina Chiara
    ONCOTARGET, 2017, 8 (35) : 59889 - 59900
  • [32] Clinical Outcomes and ALK Resistance Mutations in ALK plus Non-Small Cell Lung Cancer According to EML4-ALK Variant
    Lin, J.
    Zhu, V.
    Yoda, S.
    Yeap, B.
    Jessop, N.
    Schrock, A.
    Dagogo-Jack, I.
    Gowen, K.
    Stephens, P. J.
    Ross, J.
    Ali, S.
    Miller, V.
    Gainor, J.
    Hata, A.
    Iafrate, A.
    Ou, S.
    Shaw, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1828 - S1828
  • [33] Evaluation of EML4-ALK Fusion Proteins in Non-Small Cell Lung Cancer Using Small Molecule Inhibitors
    Li, Yongjun
    Ye, Xiaofen
    Liu, Jinfeng
    Zha, Jiping
    Pei, Lin
    NEOPLASIA, 2011, 13 (01): : 1 - U14
  • [34] Non-small Cell Lung Cancer Patients with EML4-ALK Fusion Gene Are Insensitive to Cytotoxic Chemotherapy
    Morodomi, Yosuke
    Takenoyama, Mitsuhiro
    Inamasu, Eiko
    Toyozawa, Ryo
    Kojo, Miyako
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Taguchi, Kenichi
    Seto, Takashi
    Sugio, Kenji
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (07) : 3825 - 3830
  • [35] The Biology and Clinical Features of Non-small Cell Lung Cancers with EML4-ALK Translocation
    Pillai, Rathi N.
    Ramalingam, Suresh S.
    CURRENT ONCOLOGY REPORTS, 2012, 14 (02) : 105 - 110
  • [36] Prognostic versus predictive value of EML4-ALK translocation in metastatic non-small cell lung cancer
    Shaw, A. T.
    Yeap, B.
    Costa, D. B.
    Solomon, B. J.
    Kwak, E. L.
    Nguyen, A. T.
    Bergethon, K.
    Engelman, J. A.
    Iafrate, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] EML4-ALK rearrangement detection in malignant pleural effusions from patients with advanced non-small cell lung cancer: Feasibility and predictive value.
    Zhong, Jia
    Wang, Jie
    Bai, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer
    Gower, Arjan
    Hsu, Wei-Hsun
    Hsu, Shuo-Tse
    Wang, Yisong
    Giaccone, Giuseppe
    MOLECULAR ONCOLOGY, 2016, 10 (04) : 601 - 609
  • [39] EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries
    Elshatlawy, Mariam
    Sampson, Josephina
    Clarke, Katy
    Bayliss, Richard
    MOLECULAR ONCOLOGY, 2023, 17 (06) : 950 - 963
  • [40] A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non-Small Cell Lung Cancer
    Soda, Manabu
    Isobe, Kazutoshi
    Inoue, Akira
    Maemondo, Makoto
    Oizumi, Satoshi
    Fujita, Yuka
    Gemma, Akihiko
    Yamashita, Yoshihiro
    Ueno, Toshihide
    Takeuchi, Kengo
    Choi, Young Lim
    Miyazawa, Hitoshi
    Tanaka, Tomoaki
    Hagiwara, Koichi
    Mano, Hiroyuki
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5682 - 5689
12345